These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1655433)

  • 1. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
    Chang HR; Pechère JC
    Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.
    Franco PS; Gomes AO; Barbosa BF; Angeloni MB; Silva NM; Teixeira-Carvalho A; Martins-Filho OA; Silva DA; Mineo JR; Ferro EA
    Placenta; 2011 Nov; 32(11):838-44. PubMed ID: 21908042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
    Araujo FG; Guptill DR; Remington JS
    Antimicrob Agents Chemother; 1988 May; 32(5):755-7. PubMed ID: 2840017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
    Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
    Chang HR; Rudareanu FC; Pechère JC
    J Antimicrob Chemother; 1988 Sep; 22(3):359-61. PubMed ID: 2972671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
    Lescano SA; Amato Neto V; Chieffi PP; Bezerra RC; Gakiya E; Ferreira CS; Braz LM
    Rev Soc Bras Med Trop; 2004; 37(6):460-2. PubMed ID: 15765594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
    Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
    Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
    Luft BJ
    Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effect of combined traditional Chinese medicine (Changqing capsule) on the tachyzoites of Toxoplasma gondii].
    Zhang W; Fang FR; Liu YJ; Yang LD; Luo RY; Gong F; Lu H; Xu XX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):56-8. PubMed ID: 16866146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketolide ABT-773 is active against Toxoplasma gondii.
    Khan AA; Araujo FG; Craft JC; Remington JS
    J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
    Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
    Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
    Pfefferkorn ER; Borotz SE
    Antimicrob Agents Chemother; 1994 Jan; 38(1):31-7. PubMed ID: 8141576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.
    Araujo FG; Khan AA; Slifer TL; Bryskier A; Remington JS
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2137-40. PubMed ID: 9333038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo.
    Zhang X; Jin L; Cui Z; Zhang C; Wu X; Park H; Quan H; Jin C
    Exp Parasitol; 2016 Jun; 165():95-102. PubMed ID: 26993085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.
    Ribeiro M; Franco PS; Lopes-Maria JB; Angeloni MB; Barbosa BF; Gomes AO; Castro AS; Silva RJD; Oliveira FC; Milian ICB; Martins-Filho OA; Ietta F; Mineo JR; Ferro EAV
    Exp Parasitol; 2017 Oct; 181():111-118. PubMed ID: 28803905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.